First published 10/3/2026, 1:15:15 AM · Last updated 10/3/2026, 1:15:15 AM

P29-2 Real-world treatment patterns/clinical outcomes in Japanese patients with unresectable stg III EGFRm NSCLC receiving CRT

Journal article reporting real-world treatment patterns and clinical outcomes for Japanese patients with unresectable stage III EGFR-mutant non‑small‑cell lung cancer receiving chemoradiotherapy. Publisher metadata (Elsevier BV) is provided in the excerpt but no further study details were included in the supplied source data.

Illustrative image: Photo taken right before the a dose of radiation — Jakembradford/Wikimedia Commons, CC BY-SA 4.0

Categories: public-health, science-and-space

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence: 5/10How certain the assessment is based on the clarity and evidence in the cited reporting.
Geographic reach: 4/10How widely the event reaches, from a local area (1) to worldwide impact (10).
Global importance: 3/10The event's broader significance, from limited importance (1) to major global importance (10).
Impact magnitude: 3/10The scale or severity of the real-world impact, from minor (1) to extreme (10).
Positivity: 5/10How harmful or beneficial the event is, from strongly harmful (1) to strongly positive (10).
Urgency: 2/10How time-sensitive the event is, from low urgency (1) to immediate attention needed (10).

Why it matters

The article reports clinical outcomes and treatment patterns for a defined cancer patient group.

Location

Sources

P29-2 Real-world treatment patterns/clinical outcomes in Japanese patients with unresectable stg III EGFRm NSCLC receiving CRT

Report an issue